A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH)

Autor: Ettore Capoluongo, Jacopo Gervasoni, Daniele Cappellani, Giovanni Luca Scaglione, Aniello Primiano, Elisa De Paolis, Giovanni Gambaro, Angelo Minucci, Pietro Manuel Ferraro, Claudio Marcocci, Maria De Bonis
Přispěvatelé: De Paolis, E., Minucci, A., De Bonis, M., Scaglione, G. L., Gervasoni, J., Primiano, A., Ferraro, P. M., Cappellani, D., Marcocci, C., Gambaro, G., Capoluongo, Ettore Domenico
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Clinical Biochemistry
030232 urology & nephrology
Parathyroid hormone
Bioinformatics
Biochemistry
Gastroenterology
Settore BIO/12 - BIOCHIMICA CLINICA E BIOLOGIA MOLECOLARE CLINICA
0302 clinical medicine
Medicine
Transition Temperature
Hypercalciuria
Infantile hypercalcemia
Vitamin D
Vitamin D3 24-Hydroxylase
General Medicine
Nephrocalcinosis
Molecular Diagnostic Techniques
Mutation (genetic algorithm)
Human
medicine.medical_specialty
High resolution melting analysis
Genotype
Urology
Molecular Diagnostic Technique
MEDLINE
High Resolution Melt
Melting curve analysis
03 medical and health sciences
Kidney Calculi
Text mining
CYP24A1
Internal medicine
Humans
Hypercalcemia
Idiopathic Infantile Hypercalcemia
Nephrocalcinosi
Genetic Variation
Biochemistry (medical)
business.industry
Molecular diagnostics
medicine.disease
High resolution melting analysi
030104 developmental biology
Kidney stone disease
Mutation
business
Popis: Introduction Loss-of-function mutations in cytochrome P450 family 24 subfamily A member 1 (CYP24A1) gene are associated with Idiopathic Infantile Hypercalcemia (IIH) and adult kidney stone disease. The enzyme deficiency leads to an impaired vitamin D catabolism pathway, resulting in a syndrome characterized by recurrent hypercalcemia, hypercalciuria and suppressed parathyroid hormone (PTH) levels. In these patients, the genetic evaluation of CYP24A1 is an important diagnostic tool, allowing the definitive diagnosis of IIH. Methods A rapid CYP24A1 gene testing based on High Resolution Melting Analysis (HRMA) was designed in order to detect the CYP24A1 c.428_430delAAG (p.Glu143del), a recurrent IIH-associated variant. Results HRMA method was able to identify c.428_430delAAG genotypes evaluating melting curve shape and melting temperature (Tm). Heterozygous samples exhibited a typical melting profile while homozygous samples showed a specific Tm shift. Conclusions We provide evidence about application of HRMA in unambiguous genotyping of the CYP24A1 c.428_430delAAG variant, making this method useful in clinical molecular diagnostics. This approach opens the way to a helpful molecular analysis of CYP24A1 gene in IIH diagnosis, to an improved pharmacological treatment strategy and to a reduced risk of recurrent stones and worsening nephrocalcinosis.
Databáze: OpenAIRE